Research ExplorerJournalsONCOTARGETS THER Publications

ONCOTARGETS THER

1 - 3 out of 3Page size: 50

Publications

  1. 2021

  2. Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets

    Grossmann, N. C., Schuettfort, V. M., Pradere, B., Moschini, M., Quhal, F., Mostafaei, H., Soria, F., Katayama, S., Laukhtina, E., Mori, K., Sari Motlagh, R., Poyet, C., Abufaraj, M., Karakiewicz, P. I., Shariat, S. F. & D'Andrea, D., 2021, In: ONCOTARGETS THER. 14, p. 315-324 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  3. 2016

  4. Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date

    Weisel, K., 2016, In: ONCOTARGETS THER. 9, p. 6037-6048 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  5. 2014

  6. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

    Witzel, I., Milde-Langosch, K., Schmidt, M., Karn, T., Becker, S., Wirtz, R., Rody, A., Laakmann, E., Schütze, D., Jänicke, F. & Müller, V., 28.11.2014, In: ONCOTARGETS THER. 7, p. 2205-2213 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review